EHealth stock trades without a fresh company catalyst

Published on 09/22/2026 at 18:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EHealth stock remains tied to its latest reported figures from June 2026. The company generated USD 123.1 million in first-quarter revenue and reported a USD 0.45 loss per share.

EHTH, US28238P1093, Illustration mit AI erstellt.

EHealth, Inc. (US28238P1093) remains anchored to its latest reported operating figures from June 2026, when revenue reached USD 123.1 million and the company reported a loss of USD 0.45 per share. The Nasdaq-listed stock is priced at USD 0.00 as of September 22, 2026.

Revenue remains the key figure

In the first quarter of fiscal 2026, EHealth generated USD 123.1 million in revenue, compared with USD 145.8 million in the same quarter of fiscal 2025. The year-over-year change was therefore a decline of USD 22.7 million, or 15.6 percent.

The quarterly loss was USD 0.45 per share in the June 2026 reporting period, compared with a loss of USD 0.39 per share a year earlier. That comparison shows that the lower revenue base was accompanied by a wider per-share loss of USD 0.06.

Losses keep valuation in view

EHealth's operating picture is defined by the revenue contraction and the negative earnings result rather than by a profitable growth profile. For investors, the comparison between USD 123.1 million of quarterly revenue and the USD 0.45 per-share loss is the central operating relationship in the latest period.

The stock's reference venue is Nasdaq, and the September 22, 2026 market context places the company among smaller listed healthcare businesses. The latest period remains the relevant anchor for assessing whether revenue stabilization or further cost pressure becomes the next measurable change.

Stock data for September 22

EHealth stock is listed on Nasdaq in USD. The September 22, 2026 reference price is USD 0.00, with the same date used for the market snapshot and the fact box below.